InvestorsHub Logo

H2004

11/22/17 10:44 AM

#4131 RE: TraderAKA #4128

Slight correction...Do not mean to diminish Dr. Schiff' accomplishments, but he is/was not a surgeon.

Andrew Schiff, MD, Dr. Schiff practiced internal medicine for six years at The New York Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine.

semi_infinite

11/22/17 12:09 PM

#4141 RE: TraderAKA #4128

Some are here to promote titan medical. The same hasn't posted anything informative here since the stock was way below $1. This is pretty much a useless board if you want to do DD. The signal to noise ratio here is miniscule.

Here are some numbers for you. For a well oiled hospital robotics program using the Da Vinci, or around 7-8 procedures per week per robot, the savings in instrument cost switching to Senhance lap will be around $400K per year before factoring the higher productivity per robot gained via faster set up and ease of repositioning patients during procedure as needed (instead of converting from robotics to open). But first, there is the lap procedure market to go after so ISRG followers shouldn't worry yet.